Literature DB >> 18220668

Taurine-diabetes interaction: from involvement to protection.

Sung-Jin Kim1, Ramesh C Gupta, Hyeon Woo Lee.   

Abstract

Diabetes is a complex nature. To alleviate this, nutritional intervention provides much scope and hope, and taurine has been placed under this category successfully. An adult human weighing 70 kg contains about 70 g taurine. Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus. Taurine and insulin both have mutual stimulating actions with hypoglycemic properties. On the clinical front, taurine supplementation has acceptable beneficial effect in platelet aggregation and to name a few more, in neuropathy, cardiomyopathy, nephropathy and retinopathy. Recent studies have provided a role for taurine in fetal development and also in blocking the transfer of diabetes from diabetic mother to offspring. A number of mechanisms for taurine's actions have been advocated, from osmoregulation to anti-oxidation. Though sulfonylurea and recently introduced thiazolidinediones are effective, they are also not free from complications, thus needs to design new therapeutics. As taurine is also a sulfonyl derivative and it will be of great interest to develop taurine analogues as an alternative therapy. Considering the great involvement of taurine in diabetes, this review may provide a holistic view of taurine in diabetes and in its prevention, in this century.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220668     DOI: 10.2174/157339907781368940

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  4 in total

Review 1.  Ameliorative effects of taurine against diabetes: a review.

Authors:  Fengyuan Piao; Rana Muhammad Aadil; Raheel Suleman; Kaixin Li; Mengren Zhang; Pingan Wu; Muhammad Shahbaz; Zulfiqar Ahmed
Journal:  Amino Acids       Date:  2018-02-28       Impact factor: 3.520

2.  Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.

Authors:  Kyoung Soo Kim; Da Hee Oh; Jung Yeon Kim; Bong Gn Lee; Jeong Soon You; Kyung Ja Chang; Hyun Ju Chung; Myung Chul Yoo; Hyung In Yang; Ja Heon Kang; Yoo Chul Hwang; Kue Jeong Ahn; Ho Yeon Chung; In Kyung Jeong
Journal:  Exp Mol Med       Date:  2012-11-30       Impact factor: 8.718

3.  Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease.

Authors:  Madis Parksepp; Liisa Leppik; Kadri Koch; Kärt Uppin; Raul Kangro; Liina Haring; Eero Vasar; Mihkel Zilmer
Journal:  Sci Rep       Date:  2020-08-19       Impact factor: 4.379

4.  Amino Acid Nanofibers Improve Glycemia and Confer Cognitive Therapeutic Efficacy to Bound Insulin.

Authors:  Aejin Lee; McKensie L Mason; Tao Lin; Shashi Bhushan Kumar; Devan Kowdley; Jacob H Leung; Danah Muhanna; Yuan Sun; Joana Ortega-Anaya; Lianbo Yu; Julie Fitzgerald; A Courtney DeVries; Randy J Nelson; Zachary M Weil; Rafael Jiménez-Flores; Jon R Parquette; Ouliana Ziouzenkova
Journal:  Pharmaceutics       Date:  2021-12-29       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.